← Leaderboards
Jeffrey M Testani
Yale University
$18,552,037
Attributed
$20,618,045
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2012–25$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,460,314 · 8
FDA$157,731 · 1
By mechanism
R01$19,363,734 · 6
K23$845,330 · 1
R21$251,250 · 1
U01$157,731 · 1
Top collaborators
- Michelle M Estrella8 shared
- Veena Rao2 shared
- Bhagwat Prasad1 shared
Most similar at Yale University
Same institution · by research overlap
- Jason Henry Greenberg$1,911,465
- Steven G Coca$6,183,329
- Tong Wang Wang$8,061,119
- Albert J Sinusas$22,904,679
- Mitchel R Stacy$5,154,894
Others in their field
Top investigators on “Kidney”
- Jeffrey P Krischer · University Of South Florida$540,222,210
- John M Lachin · George Washington University$155,894,464
- David M Nathan · Massachusetts Institute Of Technology$127,229,266
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$111,521,899
- David Heimbrook · Leidos Biomedical Research, Inc.$83,221,586
- Peter Scott Heeger · Case Western Reserve University$80,562,246
Research focus
KidneyHeart FailureDoseDiureticsTubular FormationNephronsResistanceResponseSodiumAcuteHospitalizationExcretory FunctionCostLiquid SubstanceNatriuresisAdultRenal FunctionLithiumPreventRandomizedDiuresisDistalGoldCohort
Grant awards (36)
Exploring water free sodium storage$735,291
R01 · FY2025 · DK · contact PI
Mechanisms of diuretic resistance in heart failure$733,353
R01 · FY2025 · DK · contact PI
Advanced Kidney Health Monitoring in Persons Hospitalized with Heart Failure$672,601
R01 · FY2025 · DK
Exploring water free sodium storage$751,928
R01 · FY2024 · DK · contact PI
Mechanisms of diuretic resistance in heart failure$704,018
R01 · FY2024 · DK · contact PI
Advanced Kidney Health Monitoring in Persons Hospitalized with Heart Failure$661,291
R01 · FY2024 · DK
Advanced Kidney Health Monitoring in Persons Hospitalized with Heart Failure$27,801
R01 · FY2024 · DK
Mechanisms of diuretic resistance in heart failure$742,504
R01 · FY2023 · DK · contact PI
Advanced Kidney Health Monitoring in Persons Hospitalized with Heart Failure$700,895
R01 · FY2023 · DK
Advanced Kidney Health Monitoring in Persons Hospitalized with Heart Failure$114,491
R01 · FY2023 · DK
Mechanism and Effects of Manipulating Chloride Homeostasis in Heart Failure$836,585
R01 · FY2022 · HL · contact PI
Cardio-Renal Effects of Torsemide vs. Furosemide: A TRANSFORM-HF Mechanistic Sub-Study$830,750
R01 · FY2022 · HL · contact PI
Mechanisms of diuretic resistance in heart failure$757,951
R01 · FY2022 · DK · contact PI
Advanced Kidney Health Monitoring in Persons Hospitalized with Heart Failure$713,146
R01 · FY2022 · DK
Kidney biomarkers in treatment for acute decompensated heart failure$96,730
R01 · FY2022 · DK
Mechanism and Effects of Manipulating Chloride Homeostasis in Heart Failure$836,075
R01 · FY2021 · HL · contact PI
Cardio-Renal Effects of Torsemide vs. Furosemide: A TRANSFORM-HF Mechanistic Sub-Study$791,162
R01 · FY2021 · HL · contact PI
Advanced Kidney Health Monitoring in Persons Hospitalized with Heart Failure$736,081
R01 · FY2021 · DK
Mechanism and Effects of Manipulating Chloride Homeostasis in Heart Failure$836,075
R01 · FY2020 · HL · contact PI
Cardio-Renal Effects of Torsemide vs. Furosemide: A TRANSFORM-HF Mechanistic Sub-Study$799,302
R01 · FY2020 · HL · contact PI
Mechanism and Effects of Manipulating Chloride Homeostasis in Heart Failure$836,075
R01 · FY2019 · HL · contact PI
Cardio-Renal Effects of Torsemide vs. Furosemide: A TRANSFORM-HF Mechanistic Sub-Study$833,910
R01 · FY2019 · HL · contact PI
Diagnosing and Targeting Mechanisms of Diuretic Resistance in Heart Failure$751,355
R01 · FY2019 · HL · contact PI
Urine galectin-3 as a biomarker of cardio-renal phenotype and prognosis$125,625
R21 · FY2019 · HL · contact PI
Mechanism and Effects of Manipulating Chloride Homeostasis in Heart Failure$837,163
R01 · FY2018 · HL · contact PI
Diagnosing and Targeting Mechanisms of Diuretic Resistance in Heart Failure$755,043
R01 · FY2018 · HL · contact PI
Urine galectin-3 as a biomarker of cardio-renal phenotype and prognosis$125,625
R21 · FY2018 · HL · contact PI
Diagnosing and Targeting Mechanisms of Diuretic Resistance in Heart Failure$735,279
R01 · FY2017 · HL · contact PI
Cardio-renal phenotype and prognosis in chronic heart failure$189,964
K23 · FY2017 · HL · contact PI
Diagnosing and Targeting Mechanisms of Diuretic Resistance in Heart Failure$735,279
R01 · FY2016 · HL · contact PI
Cardio-renal phenotype and prognosis in chronic heart failure$189,964
K23 · FY2016 · HL · contact PI
Evaluating predictive methods and product performance in Healthy Adults for Pediatric Patients, Case Study: Furosemide$157,731
U01 · FY2016 · FD · contact PI
Diagnosing and Targeting Mechanisms of Diuretic Resistance in Heart Failure$801,600
R01 · FY2015 · HL · contact PI
Cardio-renal phenotype and prognosis in chronic heart failure$155,134
K23 · FY2015 · HL · contact PI
Cardio-renal phenotype and prognosis in chronic heart failure$155,134
K23 · FY2014 · HL · contact PI
Cardio-renal phenotype and prognosis in chronic heart failure$155,134
K23 · FY2012 · HL · contact PI